{"name":"CytomX Therapeutics","slug":"cytomx-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxORHhkdm12b3FXbElxMFFHUWlYRzllOUdSSDEzQzlhdVZWODdNRXByODVhX01WdlFQd2hzeWdHOXFUTDFScnNqbGNSRmdDNGpNekhNTlBJWkdVa0ZCeVlGcHdWd0kxcXpxa3F4M1d4Wm5ZU3M0VWMwbkxyTnFRTjhjaDNPMXRJVXFqMWYtZmJJaFJuX1p0TlBhTGRDZ2taWXJtWUhzSnVHSVpJLThOaGNNZkR3?oc=5","date":"2026-03-22","type":"pipeline","source":"The Pharma Letter","summary":"The week in pharma: action, reaction and insight – week to March 20, 2026 t - The Pharma Letter","headline":"The week in pharma: action, reaction and insight – week to March 20, 2026 t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQb2VmWXR4WE81blZZQ1VqbVdrbTRyR1ZPZ0ZIcWxXZlpNc1o3cGpXaFB1TFpfd0E3X0R3aW94enZRQlRQSnBOWTRNU0hlWkUwMTQ3SHRNa1lpOURrTmJtT3N3S0o1S0RPVWl5Q3RYZXgxUXFGcEJoWHJFZFlqclVpdUkzYmVHQ05IV0N1MmxJNnBxbjZDbEQ4VFJlSy1iWFppRzBFYXJjUzg?oc=5","date":"2026-03-20","type":"pipeline","source":"Fierce Pharma","summary":"Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup - Fierce Pharma","headline":"Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQQmZ1MVg1c3gwcDdsWVVnbXZNZGJlVnQ3TDQ3ZEtoUlJRTkhfdlRIWGY5RXRVS1NiT0otMmxmQWs1RGg5bXJoaW5zMTQ4WkszcjBYaFhTWHhVTkdGbFhvZG1Eb0VJZ1R2NWxjMDZlczJULU1nUl9OQUJKUlhua1liVC00emRfQ2hUQXNyN3I0SGdXSi04dElqYzdObzlqS2VNaEhUTlZuZ1l3NFdzaE1v?oc=5","date":"2026-03-17","type":"trial","source":"BioSpace","summary":"Astellas Divorces CytomX Despite Positive Phase 1 Data for Antibody Platform - BioSpace","headline":"Astellas Divorces CytomX Despite Positive Phase 1 Data for Antibody Platform","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNRHBPNm9rR0dQRmZfNWJJelhMLUhqSWJ4Z1lHaHhfNHdjdXRnTnJ4cm42aWFqR2lfdGhkVjlmNmZCaU1vM2JuLWJGY2NwZml2NGpXTU1veS1udmFDQjZXTEw3SjFYbGZCZGhYdk8zcjRkWm8xdUpZNlN4TjlwY1lJWDJZSVdRMXdSVlRKR3lnRG5rNDl1dVRnU01tanhVUW83Sk1HZHR0Y1Q4ZVVQREtZ?oc=5","date":"2026-03-17","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Astellas Scraps Up-to-$1.7B CytomX Cancer Immunotherapy Collaboration - Genetic Engineering and Biotechnology News","headline":"Astellas Scraps Up-to-$1.7B CytomX Cancer Immunotherapy Collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOSGEzOG91REJPaDFsazVxeU5Dc1NfNDV3dmRZOUhpbmVWY3JPYlRPTC1MRXhJRVJ5NWVlVURKeTM5TlROUU8wdFpXSWFSbFVxUTZqY1FGbTFxeEl1UUpSNi12RGl3NmR1OGJCVWxILWUwS0tmUU91Z3YtRGdWb0JuNi1EYWRqeXkzR3RONExLYmFnQmtxUTdodldSOUotdHBP?oc=5","date":"2026-03-16","type":"pipeline","source":"Fierce Biotech","summary":"Astellas walks away from $1.6B biobucks T-cell engager pact with CytomX after 6 years - Fierce Biotech","headline":"Astellas walks away from $1.6B biobucks T-cell engager pact with CytomX after 6 years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOMlkxajMwYjRmYkdpV3kzUWdmTDg4d0FaUVpOS2p1WklhNmFNQ1NFcnRsWkhTZjBNSnRBUGpDNVBEVF9WYkxLZjhFMnhfUGcyVDFZWFdmb1hSY0lSXzhEVjIzVGd6R2ktbng4aU43ejVjekFVYzgyU252SjkwTU9SaFhMR1R3YUVWcXZZU2ZXaVhhTDNYQWJHQWdROG84NUtELWc?oc=5","date":"2026-03-16","type":"trial","source":"BioPharma Dive","summary":"CytomX surges on positive data for ‘masked’ ADC in colorectal cancer - BioPharma Dive","headline":"CytomX surges on positive data for ‘masked’ ADC in colorectal cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeXZ6SnJKRElYd0VkdUpkaF9lc3U5dzlJQ1FDRmN2eU9lT2s4OXQyZTVCY0x6ODVWZDhqZnhhMmZXblVNZFZmcGgxcFByUGk3UzVKQ0NLX212djkzanBmM3R5QklDYU5nYXpQQ0hxMFhHcFAyR3lJaVVMNThsc291WjQtZDRhWVBPLUV3Q2FBS3c0NkxJb1ltQ3dMZ1pVbV9aN3hQYzJQcXc?oc=5","date":"2026-01-05","type":"pipeline","source":"Investing News Network","summary":"Top 5 Small-cap Pharma Stocks (Updated January 2026) - Investing News Network","headline":"Top 5 Small-cap Pharma Stocks (Updated January 2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE8tU2I0QW5iLVVMTFliNE5MekNWWjRtRU9IRVJfa3lpRXh4aE9uZXZKd3RNT2c3dDVEYzZONWxRY21zdnA5bFRlZXpqa1dLTFNMV1h3?oc=5","date":"2025-08-13","type":"trial","source":"FirstWord Pharma","summary":"CytomX continues Phase I ADC study after patient death - FirstWord Pharma","headline":"CytomX continues Phase I ADC study after patient death","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcXlRS1hROWg2Y0dvclFfVEYwUW9Ua3N3WV9Ybkl5Ynd5bjluS1R1ZWluRFRaZl9QdE5mUU5kVUo4RDhjeVhQdlBoM2NNNjVlV1J5UkowNTgzd3ktRFpneXljVkZhd2ZjTXZ5NFhwanhhYXZQYm5iYzI0MTh1UklJNU5HcEhDVm5vREFOaXZKdnYtTnJEb3piTi1IY2g4WnlJcXoweVl5VF94UQ?oc=5","date":"2025-01-07","type":"deal","source":"Fierce Biotech","summary":"CytomX lays off 40% of staff, questions future of Amgen-partnered T-cell engager - Fierce Biotech","headline":"CytomX lays off 40% of staff, questions future of Amgen-partnered T-cell engager","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPekdZdDBfRzNkVXVfVTQ1a0RqckhrTUg3MXM4RjlKOFR1WHBQZmlaa3ozSUNoZE9TSWszZy1NTWdvcGNlN18tY3NLOE9SYmFFUFVFb0RPa2RiUmJWbENNaGN6NnNTc0FJMjRxVDh6NU9LRVNQQmpEblFRRzZEeWpwN2VULXAxT0xGZi1v?oc=5","date":"2024-04-03","type":"pipeline","source":"Contract Pharma","summary":"CytomX Achieves $5M Astellas Milestone - Contract Pharma","headline":"CytomX Achieves $5M Astellas Milestone","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQcTl2ZEthVFFqdlVNb1NlRGtndGZKYWtNbDIwVE9QMXN6RlV4anMzWVIwSkJjOGtDaWl2dG0tNHIzb1NBTENtMEhMOVVuUGRlSG9QRGRFeGVwV1FLTUlRR1BBYTRpMmVVdXMwUllfT0dXblBPRV84d05lRGtXUm9jeFU5Q2xFVFAtUUFrclBhdE5tbW0yTmtlVEoxSEhMUQ?oc=5","date":"2022-11-18","type":"pipeline","source":"pharmaphorum","summary":"Regeneron, CytomX announce bispecific therapeutics for cancer collab - pharmaphorum","headline":"Regeneron, CytomX announce bispecific therapeutics for cancer collab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNeXFud1pkSWsxSzNhM3dTcFJLUVotUDF3YTBtMnRBVmpLODcwVnRqeFI2TjVkWnNTUGRtVHFNQlhrXzBKWEtCT3BCSUc5Qm8wdlR0QTgtWGxFYjlHV1RxZk1oOEJDa0lYN2tSbkxWRFZsZkk4eS0xZXc5emFwN2J6M1ViRVY3bENJZERqeDZBemk2dw?oc=5","date":"2022-11-17","type":"pipeline","source":"BioPharma Dive","summary":"Regeneron teams up with CytomX to develop dual-targeting cancer drugs - BioPharma Dive","headline":"Regeneron teams up with CytomX to develop dual-targeting cancer drugs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}